Laurus Labs Approves Voluntary Closure of German Subsidiary

Laurus Labs Board approves voluntary closure of its step-down German subsidiary, Laurus Generics GmbH.
The subsidiary reported nil turnover and a negative net worth of (₹10.53 lakh) for FY March 31, 2026.
The closure is subject to German regulatory approvals and will have no material financial impact on the company.
Disclosure is made pursuant to SEBI Listing Regulations and Master Circular dated January 30, 2026.